Sarah Cross, Ph.D.

Dr. Sarah Cross is the Vice President and Global Head of Medical Affairs at Premier Research. In her role, she oversees strategic planning and management of the global medical affairs team across therapeutic areas, including neurology, immunology, oncology, women’s health, internal and pediatric medicine, and rare disease.

Previously Dr. Cross held roles within the CRO, pharma, and biotech/medtech industries, including various leadership positions across pharma and clinical research organizations. She has supported both early and late phase pipeline drug development and has a strong track record delivering medical affairs leadership for critical launch assets resulting in several global drug approvals, primarily within the immunology and specialty divisions at AbbVie.

Dr. Cross leads a team of medical experts at Premier Research who are dedicated to helping sponsors and clinical operations teams navigate the scientific complexities of clinical research. With her oversight, the Medical Affairs team provides a number of strategic services including medical expertise to inform study design and clinical trial execution, leadership and training of study teams to ensure disease state and protocol comprehension, medical monitoring services, KOL/PI engagement, and scientific input for asset development planning and regulatory agency interactions.

Dr. Cross holds a BS in Chemistry from the University of California, Santa Barbara (UCSB) and a Ph.D. in Chemistry from the University of California, Los Angeles (UCLA). She is passionate about advancing novel therapeutics and medical devices to address unmet patient needs through best-in-class strategic partnerships, quality clinical trial support, and medical affairs excellence.